AMUB:NYE-UBS AG London Branch ELKS 5 (USD)

ETF | Energy Limited Partnership |

Last Closing

USD 18.681

Change

0.00 (0.00)%

Market Cap

USD 0.07B

Volume

100.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The ETRACS Alerian MLP Index ETN Series B due July 18, 2042 (the "Securities") is senior unsecured debt securities issued by UBS. The index measures the composite performance of energy master limited partnerships ("MLPs"), and is calculated by S&P Dow Jones Indices using a float-adjusted, capitalization-weighted methodology.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-17 )

Largest Industry Peers for Energy Limited Partnership

ETFs Containing AMUB

SEUC:LSE SPDR® Bloomberg 0-3 Year.. 0.28 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Energy Limited Partnership) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.73% 30% F 70% C-
Dividend Return 5.19% 50% F 73% C
Total Return 21.91% 30% F 75% C
Trailing 12 Months  
Capital Gain 15.54% 30% F 56% F
Dividend Return 6.82% 70% C- 77% C+
Total Return 22.35% 30% F 61% D-
Trailing 5 Years  
Capital Gain 38.64% 50% F 66% D+
Dividend Return 35.77% 70% C- 87% B+
Total Return 74.42% 60% D- 75% C
Average Annual (5 Year Horizon)  
Capital Gain 19.76% 60% D- 81% B-
Dividend Return 26.82% 60% D- 84% B
Total Return 7.06% 70% C- 92% A
Risk Return Profile  
Volatility (Standard Deviation) 22.82% 70% C- 48% F
Risk Adjusted Return 117.53% 100% F 99% N/A
Market Capitalization 0.07B 25% F 23% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.